Please login to the form below

tenofovir alafenamide

This page shows the latest tenofovir alafenamide news and features for those working in and with pharma, biotech and healthcare.

Gilead builds case for Descovy PrEP after FDA approval

Descovy (emtricitabine/tenofovir alafenamide) claimed its FDA approval for PrEP last week – becoming only the second drug for this use since Gilead’s Truvada (emtricitabine/tenofovir disoproxil fumarate) got a green

Latest news

J&J pledges $500m investment into HIV and tuberculosis R&D

and tenofovir alafenamide) was recently approved by the FDA.
Gilead claims FDA okay for Descovy as second PrEP option

Descovy (emtricitabine and tenofovir alafenamide) has been cleared for adolescents and adults who are at risk of HIV infection because they have sex with an HIV-positive partner. ... In a statement, the FDA said that Descovy’s efficacy in preventing
ViiV builds case for switching to its two-drug HIV combinations

48-week data from the phase 3 TANGO study indicates that Dovato (dolutegravir/lamivudine) was just as effective as triple therapies that included Gilead’s tenofovir alafenamide fumarate (TAF) at suppressing
ViiV bags EU okay for new two-drug HIV therapy

bictegravir/emtricitabine/tenofovir alafenamide) product.
Shingrix lifts GSK in Q1, but two more vaccines are culled

such as Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) has started to chip away at growth levels.

More from news
Approximately 4 fully matching, plus 40 partially matching documents found.

Latest Intelligence

Choices, choices: the rapidly evolving HIV treatment landscape

With Triumeq signalling the approval of the first STR without tenofovir disoproxil fumarate (TDF) it can, uniquely, be used in those patients with impaired kidney function. ... Gilead, in hot pursuit, is in phase III of development of a new regimen where

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Scientific Director - Medical Education - Cheshire & London ...: Excellent Remuneration Package

Programme Manager / Programme Director – Medical Education - Buc...: Salary TBC

Account Director – Cheshire based Medical Communications Agency...: D.O.E

Senior Medical Writer – Leading Medical Communications Agency – ...: Highly Competitive Remuneration Package

Scientific Director - Medical Communications Agency - New York: Excellent Remuneration Package

Experienced / Senior Medical Writer - MedComms - Cardiff - Wales: Excellent Salary and Benefits on offer

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Senior / Principal Medical Writer – Medical Education - UK &...: Excellent Salary and Benefits on offer

Senior Medical Writer– Medical Education – Oxford - London: Excellent Remuneration Package

Account Director, Medical Education: Salary TBC

Account Manager / Senior Account Manager - Creative MedComms - C...: Excellent Remuneration

Graduate / Entry Level Opportunities – Medical Communications – ...: Highly Competitive Remuneration Package

Senior Medical Writer: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

The 2019 CPhI Pharma Index Report: Examining this year’s industry performance...
Five key trends in precision and personalised healthcare: Here, we deep dive into five of the key trends in precision medicine and personalised healthcare to explore how the healthcare industry is changing and how pharmaceutical and biotech companies...
OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications: Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...